• Home
      • StockReports™Analyse your stocks in seconds
      • Stock ResearchExpert insight you can understand
      • StockRanks™Identify winning stocks
      • ScreenersGenerate investing ideas fast
      • PortfoliosMonitor and improve your performance
      • Charts and toolsTime your trades better
      • Academy
        • All topics
        • Analyse stocks
        • Discover stocks
        • Investment strategy
        • Portfolio management
      • Additional resources
        • Events
        • Product guides
        • Ratio glossary
        • Newsletter
        • Companies & markets
    • Reviews
    • Pricing
    • About
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNLS Pharmaceutics AG
    Picture of NLS Pharmaceutics AG logo

    NLSP — NLS Pharmaceutics AG Share News

    $2.330.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $8.38m
    • Enterprise Value
      $9.46m
    • Revenue
    • Quality
      10
    • Value
      18
    • Momentum
      24
    • StockRank™
      6
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NLSP Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NLSP Dividends
    • RCS - NLS Pharmaceutics AG - NLS Pharmaceutics Announces an R&D Update Webcast

      12/01/2023 15:00Announcement
    • RCS - NLS Pharmaceutics AG - NLS Pharmaceutics Announces Closing of Initial

      14/12/2022 14:45Announcement
    • RCS - NLS Pharmaceutics AG - NLS Pharmaceutics Announces Purchase Agreement

      07/12/2022 14:30Announcement
    • RCS - NLS Pharmaceutics AG - NLS Pharmaceutics Announces Launch of Program

      23/11/2022 14:30Announcement

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2025, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.